OLR1 and endothelial dysfunction: The natural antioxidant and LOX-1 modulating properties of BEO-NVF appear to be promising for use in MetS to decrease endothelial dysfunction, smooth muscle cell proliferation and inflammation, all of which bridge the gap between MetS and ASCVD.